Abstract
Chloramphenicol has been reported to act as an inducer of the multidrug resistance in Escherichia coli. A resistant variant able to grow on plates containing 64 microg/ml chloramphenicol was obtained from the Enterobacter aerogenes ATCC 13048-type strain. Chloramphenicol resistance was due to an active efflux of this antibiotic and it was associated with resistance to fluoroquinolones and tetracycline, but not to aminoglycoside or beta-lactam antibiotics. MDR in the chloramphenicol-resistant variant is linked to the overexpression of the major AcrAB-TolC efflux system. This overexpression seems unrelated to the global Mar and the local AcrR regulatory pathways.
MeSH terms
-
ATP Binding Cassette Transporter, Subfamily B / drug effects
-
ATP Binding Cassette Transporter, Subfamily B / metabolism
-
Anti-Bacterial Agents / pharmacokinetics
-
Anti-Bacterial Agents / pharmacology
-
Bacterial Proteins / antagonists & inhibitors*
-
Bacterial Proteins / metabolism*
-
Carrier Proteins / antagonists & inhibitors*
-
Carrier Proteins / metabolism*
-
Chloramphenicol / pharmacokinetics*
-
Chloramphenicol / pharmacology*
-
Dose-Response Relationship, Drug
-
Drug Resistance, Multiple, Bacterial / drug effects
-
Drug Resistance, Multiple, Bacterial / physiology*
-
Enterobacter aerogenes / classification
-
Enterobacter aerogenes / drug effects*
-
Enterobacter aerogenes / metabolism*
-
Gene Expression Regulation, Bacterial / drug effects
-
Metabolic Clearance Rate
-
Species Specificity
Substances
-
ATP Binding Cassette Transporter, Subfamily B
-
AcrAB-TolC protein, Salmonella enterica
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Carrier Proteins
-
Chloramphenicol